Morton Grove, IL, United States of America

Dominique Bridon


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Dominique Bridon in Alkaline Phosphatase Inhibition

Introduction

Dominique Bridon is an accomplished inventor based in Morton Grove, IL (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as alkaline phosphatase inhibitors. Her work has implications for various therapeutic applications, including cancer treatment and anti-depressive therapies.

Latest Patents

Dominique Bridon holds a patent for "Compounds useful as alkaline phosphatase inhibitors and therapeutic agents." This patent discloses novel compounds that selectively inhibit human alkaline phosphatases, distinguishing them from Escherichia coli alkaline phosphatases. The compounds can be utilized as cancer therapeutic agents, anti-depressive agents, anti-anergic agents, and antihelminthic agents. The general formula of these compounds includes various substituents, allowing for a range of applications in therapeutic settings.

Career Highlights

Bridon is currently associated with Abbott Laboratories Corporation, where she continues her research and development efforts. Her innovative work has led to advancements in the understanding and treatment of diseases related to alkaline phosphatase activity. With a focus on therapeutic agents, she has positioned herself as a key figure in her field.

Collaborations

Dominique has collaborated with notable colleagues, including Mazhar Husain and Mark Bures. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.

Conclusion

Dominique Bridon's contributions to the field of alkaline phosphatase inhibitors highlight her innovative spirit and dedication to advancing medical science. Her work at Abbott Laboratories Corporation and her patent for novel compounds underscore her impact on therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…